Choreo LLC’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.44M | Buy |
46,209
+745
| +2% | +$104K | 0.08% | 187 |
|
|
2025
Q4 | $5.6M | Sell |
45,464
-3,069
| -6% | -$373K | 0.07% | 189 |
|
|
2025
Q3 | $5.39M | Buy |
48,533
+681
| +1% | +$77.4K | 0.07% | 192 |
|
|
2025
Q2 | $5.31M | Buy |
47,852
+498
| +1% | +$53K | 0.07% | 185 |
|
|
2025
Q1 | $5.31M | Sell |
47,354
-7,178
| -13% | -$741K | 0.08% | 172 |
|
|
2024
Q4 | $5.02M | Sell |
54,532
-135
| -0.2% | -$12.2K | 0.07% | 185 |
|
|
2024
Q3 | $4.59M | Buy |
54,667
+9,166
| +20% | +$699K | 0.07% | 199 |
|
|
2024
Q2 | $3.12M | Buy |
45,501
+35,538
| +357% | +$2.37M | 0.05% | 231 |
|
|
2024
Q1 | $730K | Buy |
9,963
+1,816
| +22% | +$140K | 0.02% | 337 |
|
|
2023
Q4 | $660K | Buy |
8,147
+2,844
| +54% | +$221K | 0.02% | 337 |
|
|
2023
Q3 | $397K | Buy |
5,303
+142
| +3% | +$10.9K | 0.01% | 318 |
|
|
2023
Q2 | $398K | Sell |
5,161
-72
| -1% | -$5.74K | 0.01% | 333 |
|
|
2023
Q1 | $434K | Buy |
+5,233
| New | +$433K | 0.02% | 322 |
|
|
2018
Q4 | – | Sell |
-3,527
| Closed | -$272K | – | 197 |
|
|
2018
Q3 | $272K | Sell |
3,527
-664
| -16% | -$50.1K | 0.04% | 179 |
|
|
2018
Q2 | $297K | Sell |
4,191
-1,995
| -32% | -$141K | 0.04% | 186 |
|
|
2018
Q1 | $466K | Buy |
6,186
+451
| +8% | +$35.9K | 0.06% | 163 |
|
|
2017
Q4 | $411K | Buy |
5,735
+159
| +3% | +$12.1K | 0.05% | 182 |
|
|
2017
Q3 | $452K | Buy |
5,576
+1,096
| +24% | +$83.8K | 0.06% | 164 |
|
|
2017
Q2 | $317K | Sell |
4,480
-941
| -17% | -$62.6K | 0.04% | 201 |
|
|
2017
Q1 | $368K | Buy |
5,421
+748
| +16% | +$52.6K | 0.05% | 182 |
|
|
2016
Q4 | $335K | Sell |
4,673
-3,849
| -45% | -$286K | 0.05% | 180 |
|
|
2016
Q3 | $674K | Sell |
8,522
-413
| -5% | -$33.5K | 0.12% | 96 |
|
|
2016
Q2 | $745K | Buy |
8,935
+2,195
| +33% | +$195K | 0.14% | 86 |
|
|
2016
Q1 | $619K | Buy |
6,740
+3,498
| +108% | +$315K | 0.12% | 86 |
|
|
2015
Q4 | $328K | Buy |
3,242
+480
| +17% | +$49.9K | 0.08% | 110 |
|
|
2015
Q3 | $271K | Buy |
2,762
+522
| +23% | +$58K | 0.07% | 116 |
|
|
2015
Q2 | $262K | Buy |
2,240
+198
| +10% | +$21.6K | 0.07% | 118 |
|
|
2015
Q1 | $200K | Buy |
+2,042
| New | +$207K | 0.05% | 145 |
|
|
2014
Q4 | – | Sell |
-2,611
| Closed | -$278K | – | 151 |
|
|
2014
Q3 | $278K | Buy |
+2,611
| New | +$256K | 0.08% | 114 |
|
|
2014
Q2 | – | Sell |
-4,533
| Closed | -$321K | – | 150 |
|
|
2014
Q1 | $321K | Buy |
+4,533
| New | +$356K | 0.09% | 103 |
|
Other funds holding GILD
VCM
VPM
Choreo LLC's GILD Position: Q1 2026 in Review
Choreo LLC increased its Gilead Sciences (GILD) stake by 1.6% in Q1 2026, buying an estimated $104K and bringing the position to 46,209 shares worth $6.44M. The position accounts for 0.08% of the portfolio, ranked #187.
Choreo LLC first reported a position in GILD in Q1 2014 and has held it in 30 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Choreo LLC held 46,209 shares of Gilead Sciences worth $6.44M as of Q1 2026.
- Choreo LLC bought 745 Gilead Sciences shares in Q1 2026, an estimated $104K.
- Gilead Sciences made up 0.08% of Choreo LLC's portfolio in Q1 2026, its #187 holding.
- Choreo LLC first reported a position in Gilead Sciences in Q1 2014 and has held it in 30 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.